Claims for Patent: 4,421,762

Summary for Patent: 4,421,762

Title:	Method of treatment of an allergy to an ingested allergen
Abstract:	There is described a method of treatment of allergy to ingested allergens, which comprises per os administration of a daily dosage of from 20 to 4,000 mg of 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane or a therapeutically acceptable salt thereof to a patient having such an allergy.
Inventor(s):	Wardell; George (Loughborough, GB2)
Assignee:	Fisons Limited (London, GB2)
Application Number:	06/300,281
Patent Claims:	1. A method of treatment of an allergy to an ingested allergen, which comprises per os administration of a daily dosage of from 20 to 4,000 mg of 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane or a therapeutically acceptable salt thereof, as active ingredient to a patient having such an allergy. 2. The method of claim 1, wherein the salt is an ammonium, alkali metal or alkaline earth metal salt. 3. The method of claim 1, wherein the compound is the disodium salt of 1,3-bis(2-carboxychromon-5-yloxy)-2-hydropropane. 4. The method of claim 1, wherein the patient receives unit doses of from 20 to 1,000 mg of the active ingredient. 5. The method of claim 4, wherein the unit doses are from 100 to 750 mg of active ingredient. 6. The method of claim 5, wherein the unit doses are from 200 to 500 mg of active ingredient. 7. The method of claim 1, wherein the patient receives from 40 to 1,000 mg of active ingredient per day. 8. The method of claim 1, wherein the allergy treated is an allergy to ingested milk, eggs, fruit, fish, nuts, shellfish, meat, vegetables or cereal flour.